Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 3282656, 13 pages
https://doi.org/10.1155/2017/3282656
Research Article

Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy

1Gonçalo Moniz Institute, FIOCRUZ, Salvador, BA, Brazil
2Center for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, BA, Brazil

Correspondence should be addressed to Milena Botelho Pereira Soares; rb.zurcoif.aihab@anelim

Received 10 February 2017; Revised 27 May 2017; Accepted 5 June 2017; Published 10 July 2017

Academic Editor: Luc van der Laan

Copyright © 2017 Bruno Solano de Freitas Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, “The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells,” Cell and Tissue Kinetics, vol. 3, no. 4, pp. 393–403, 1970. View at Google Scholar
  3. F. Gao, S. M. Chiu, D. A. Motan et al., “Mesenchymal stem cells and immunomodulation: current status and future prospects,” Cell Death & Disease, vol. 7, article e2062, 2016. View at Publisher · View at Google Scholar
  4. M. Sioud, A. Mobergslien, A. Boudabous, and Y. Fløisand, “Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins,” International Journal of Oncology, vol. 38, no. 2, pp. 385–390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sioud, A. Mobergslien, A. Boudabous, and Y. Fløisand, “Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation,” Scandinavian Journal of Immunology, vol. 71, no. 4, pp. 267–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Krześlak and A. Lipińska, “Galectin-3 as a multifunctional protein,” Cellular & Molecular Biology Letters, vol. 9, no. 2, pp. 305–328, 2004. View at Google Scholar
  7. A. C. Mackinnon, M. A. Gibbons, S. L. Farnworth et al., “Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 5, pp. 537–546, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. C. Henderson, A. C. Mackinnon, S. L. Farnworth et al., “Galectin-3 regulates myofibroblast activation and hepatic fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5060–5065, 2006. View at Google Scholar
  9. M. Kolatsi-Joannou, K. L. Price, P. J. Winyard, and D. A. Long, “Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury,” PLoS One, vol. 6, no. 4, article e18683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Y. Wan, T. F. Zhang, and Y. Ding, “Galectin-3 enhances proliferation and angiogenesis of endothelial cells differentiated from bone marrow mesenchymal stem cells,” Transplantation Proceedings, vol. 43, no. 10, pp. 3933–3938, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. N. C. Henderson and T. Sethi, “The regulation of inflammation by galectin-3,” Immunological Reviews, vol. 230, no. 1, pp. 160–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. C. Nunes, W. Dones, C. A. Morillo, J. J. Encina, A. L. Ribeiro, and Council on Chagas Disease of the Interamerican Society of Cardiology, “Chagas disease: an overview of clinical and epidemiological aspects,” Journal of the American College of Cardiology, vol. 62, no. 9, pp. 767–776, 2013. View at Google Scholar
  13. M. B. Soares, L. Pontes-De-Carvalho, and R. Ribeiro-Dos-Santos, “The pathogenesis of Chagas’ disease: when autoimmune and parasite-specific immune responses meet,” Anais da Academia Brasileira de Ciências, vol. 73, no. 4, pp. 547–559, 2001. View at Publisher · View at Google Scholar
  14. T. F. Larocca, B. S. Souza, C. A. Silva et al., “Transplantation of adipose tissue mesenchymal stem cells in experimental chronic chagasic cardiopathy,” Arquivos Brasileiros de Cardiologia, vol. 100, no. 5, pp. 460–468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. N. Silva, B. S. de Freitas Souza, C. M. Azevedo et al., “Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy,” Stem Cell Research & Therapy, vol. 5, no. 4, p. 81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Jasmin, L. A. Jelicks, H. B. Tanowitz et al., “Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease,” Microbes and Infection, vol. 16, no. 11, pp. 923–935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. B. Soares, R. S. Lima, B. S. Souza et al., “Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells,” Cell Cycle, vol. 10, no. 9, pp. 1448–1455, 2011. View at Google Scholar
  18. B. S. F. Souza, D. N. Silva, R. H. Carvalho et al., “Association of Cardiac galectin-3 expression, myocarditis, and fibrosis in chronic Chagas disease cardiomyopathy,” The American Journal of Pathology, vol. 187, no. 5, pp. 1134–1146, 2017. View at Publisher · View at Google Scholar
  19. T. N. Moody, J. Ochieng, and F. Villalta, “Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3,” FEBS Letters, vol. 470, no. 3, pp. 305–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Y. Kleshchenko, T. N. Moody, V. A. Furtak, J. Ochieng, M. F. Lima, and F. Villalta, “Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells,” Infection and Immunity, vol. 72, no. 11, pp. 6717–6721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. C. Reignault, E. S. Barrias, L. C. Soares Medeiros, W. de Souza, and T. M. de Carvalho, “Structures containing galectin-3 are recruited to the parasitophorous vacuole containing Trypanosoma cruzi in mouse peritoneal macrophages,” Parasitology Research, vol. 113, no. 6, pp. 2323–2333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. E. V. Acosta-Rodríguez, C. L. Montes, C. C. Motrán et al., “Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection,” Journal of Immunology, vol. 172, no. 1, pp. 493–502, 2004. View at Publisher · View at Google Scholar
  23. E. Silva-Monteiro, L. Reis Lorenzato, O. Kenji Nihei et al., “Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection,” The American Journal of Pathology, vol. 170, no. 2, pp. 546–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. Soares, R. S. de Lima, L. L. Rocha et al., “Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy,” The Journal of Infectious Diseases, vol. 202, no. 3, pp. 416–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Danella Polli, K. Alves Toledo, L. H. Franco et al., “Monocyte migration driven by galectin-3 occurs through distinct mechanisms involving selective interactions with the extracellular matrix,” ISRN Inflammation, vol. 2013, Article ID 259256, 9 pages, 2013. View at Publisher · View at Google Scholar
  26. X. Gao, V. Balan, G. Tai, and A. Raz, “Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway,” Oncotarget, vol. 5, no. 8, pp. 2077–2084, 2014. View at Publisher · View at Google Scholar
  27. T. C. Cardenas, C. A. Johnson, S. Pratap et al., “Regulation of the extracellular matrix interactome by Trypanosoma cruzi,” The Open Parasitology Journal, vol. 4, pp. 72–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Fortuna-Costa, A. M. Gomes, E. O. Kozlowski, M. P. Stelling, and M. S. Pavão, “Extracellular galectin-3 in tumor progression and metastasis,” Frontiers in Oncology, vol. 4, p. 138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Gao, Y. Xia, L. Liu et al., “Galectin-3 enhances migration of minature pig bone marrow mesenchymal stem cells through inhibition of RhoA-GTP activity,” Scientific Reports, vol. 6, article 26577, 2016. View at Google Scholar
  30. J. Leibacher and R. Henschler, “Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells,” Stem Cell Research & Therapy, vol. 7, p. 7, 2016. View at Google Scholar
  31. F. K. Swirski, M. Nahrendorf, M. Etzrodt et al., “Identification of splenic reservoir monocytes and their deployment to inflammatory sites,” Science, vol. 325, no. 5940, pp. 612–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Acosta, N. Tajiri, J. Hoover, Y. Kaneko, and C. V. Borlongan, “Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke,” Stroke, vol. 46, no. 9, pp. 2616–2627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. B. L. Yen, M. L. Yen, P. J. Hsu et al., “Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3,” Stem Cell Reports, vol. 1, no. 2, pp. 139–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Cuervo, N. A. Guerrero, S. Carbajosa et al., “Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection,” Journal of Immunology, vol. 187, no. 5, pp. 2656–2665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. B. Mello, I. P. Ramos, F. C. Mesquita et al., “Adipose tissue-derived mesenchymal stromal cells protect mice infected with Trypanosoma cruzi from cardiac damage through modulation of anti-parasite immunity,” PLoS Neglected Tropical Diseases, vol. 9, no. 8, article e0003945, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. A. V. Ferreira, M. Segatto, Z. Menezes et al., “Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease,” Microbes and Infection, vol. 13, no. 12-13, pp. 1002–1005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. F. C. Machado, L. Cruz, A. A. da Silva et al., “Recruitment of galectin-3 during cell invasion and intracellular trafficking of Trypanosoma cruzi extracellular amastigotes,” Glycobiology, vol. 24, no. 2, pp. 179–184, 2014. View at Publisher · View at Google Scholar · View at Scopus